Merck & Co., Inc.

Holdings History for Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

Symbol: EVAX on Nasdaq
Investment type: Equity - Shares of Stock
Class: American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
Latest Disclosed Ownership: 63M shares
Security Ownership: 20%

Shares, Excluding Options vs Price

Value, Excluding Options

Merck & Co., Inc. ownership in Evaxion Biotech A/S American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)

2025-02-03 - Merck & Co., Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 63M shares of Evaxion Biotech A/S American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX). This represents 20% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Merck & Co., Inc.	19.96%		$94.5M	63M			$1.50	13G/A	1/31/2025	3 Feb 2025 16:15:22

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024		0.18%		$458K	542K			$0.85	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.